How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow” [version 1; referees: 2 approved]
Leif D. Nelin, Vineet Bhandari
F1000Research · 2017
doi:10.12688/f1000research.10832.1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Bronchopulmonary dysplasia, or BPD, is the most common chronic lung disease in infants. Genetic predisposition and developmental vulnerability secondary to antenatal and postnatal infections, compounded with exposure to hyperoxia and invasive mechanical ventilation to an immature lung, result in persistent inflammation, culminating in the characteristic pulmonary phenotype of BPD of impaired alveolarization and dysregulated vascularization. In this article, we highlight specific areas in current management, and speculate on therapeutic strategies that are on the horizon, that we believe will make an impact in decreasing the incidence of BPD in your neonatal intensive care units.
Abstract licence: CC BY
References63
- 39.
39 more references, whose wording the paper’s licence keeps private.
All 63 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.